trial · primary record
TAS102+Nedaplatin
Gastric Cancer (GC)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 36 |
| Primary completion | 2028-12-01 |
| Primary endpoint | Progression-free survival (PFS) |
| Registry ID | NCT07913165 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:41.013Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07913165
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.